Bone Marrow Transplant Market Size, Share, Growth Analysis 2023

According to Precision Business Insights' (PBI) latest report, the bone marrow transplant market size was valued at USD 10.28 billion in 2022 and is poised to grow at a CAGR of 4.0% during the forecast period 2023-29. The global bone marrow transplant market One of the key trends in the global bone marrow transplant market is the increasing utilization of haploidentical transplants. Haploidentical transplants involve using a partially matched donor, typically a family member, which expands the pool of potential donors. Advancements in transplantation techniques, such as improved conditioning regimens and post-transplant care, have made haploidentical transplants a viable and effective option. This trend addresses the challenge of donor availability and is expected to fuel the growth of the bone marrow transplant market globally.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/bone-marrow-transplant-market

The global bone marrow transplant market is segmented based on by type, by treatment, by end user and geography.
1) By Type
Autologous Transplant,
Allogeneic Transplant, and
Others

2) By Treatment Type
Leukemia, Lymphoma,
Myeloma,
Myelodysplastic Syndrome,
Myeloproliferative Disorders,
Aplastic Anemia, Solid Tumors,
Sickle cell Anemia, Thalassemia, and
Others

3) By End User
Hospitals,
Multi-specialty Clinics, and
Ambulatory Surgical Centers

Autologous Transplant Segment Dominate The Bone Marrow Transplant Market:
The Autologous Transplant segment is anticipated to be more significant in the global bone marrow transplant market. Autologous bone marrow transplant refers to the transplantation of a patient's own bone marrow cells, which are collected and preserved before undergoing intensive treatment. This segment is expected to witness substantial growth due to several factors. Autologous transplants eliminate the risk of graft-versus-host disease (GVHD) as there is no donor involvement. Additionally, advancements in cell collection and storage techniques have improved the availability and quality of autologous bone marrow cells. The increasing utilization of autologous transplants in treating conditions such as lymphoma and multiple myeloma further contributes to the prominence of this segment in the market.

Asia Pacific Leads the Global Bone Marrow Transplant Market.
Asia Pacific, the Bone Marrow Transplant market holds a market share of 31% in 2022 and the market is expected to grow at a significant CAGR during the forecast period. Many countries in the Asia Pacific region have been investing in enhancing their healthcare infrastructure and expertise in the field of bone marrow transplantation. Governments and private entities have focused on expanding transplant centres, upgrading medical facilities, and training healthcare professionals to perform these procedures. This improved infrastructure and expertise have increased the accessibility and availability of bone marrow transplants, contributing to market growth.

Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=327392

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The bone marrow transplant market further reveals that the key players increasingly adopting strategies such as the launch of newer products, frequent product approvals, and long-term alliances to improve market revenue share and gaining significant geographic presence across the region. In March 2022, Novartis and Adaptimmune Therapeutics announced a collaboration to develop and commercialize T-cell therapies for cancer. The collaboration will combine Novartis' global reach and commercial expertise with Adaptimmune Therapeutics' expertise in T-cell therapy technology. In April 2022, Sanofi and Regeneron Pharmaceuticals announced a collaboration to develop and commercialize CAR T-cell therapies for blood cancers. The collaboration will combine Sanofi's global reach and commercial expertise with Regeneron Pharmaceuticals' expertise in immune oncology.

Key players in the bone marrow transplant market report are Lonza, Merck KgaA, Sanofi, AllCells, STEMCELL Technologies Inc., Charles River Laboratories, Beike Biotechnology Co., Ltd., FUJIFILM Cellular Dynamics, Inc., CORESTEM, Inc., Gamida Cell, Lifeline Cell Technology, Mesoblast Ltd, PromoCell GmbH.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.